Felix Bormann

Title: Felix Bormann: Innovator in Antibody Technology

Introduction

Felix Bormann is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. His innovative approach has the potential to enhance therapeutic applications in various medical fields.

Latest Patents

Felix Bormann holds a patent for a method titled "Method for generating multispecific antibodies from monospecific antibodies." This patent describes a technique for generating multispecific antibodies through a half-antibody exchange reaction between two 2/3-IgGs. The method allows for the generation of correctly assembled full-length bispecific antibodies without the need for reducing agents or hinge region disulfide bonds in the starting 2/3-IgGs. He has 1 patent to his name.

Career Highlights

Throughout his career, Felix Bormann has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His work has contributed to advancements in antibody technology, which is crucial for developing new treatments.

Collaborations

Felix has collaborated with esteemed colleagues such as Ulrich Brinkmann and Stefan Dengl. These partnerships have fostered innovation and have been instrumental in his research endeavors.

Conclusion

Felix Bormann's contributions to the field of antibody technology exemplify the impact of innovative thinking in biotechnology. His work continues to influence the development of new therapeutic strategies.